Lamotrigine Tablet
Product Images NDC 59746-245

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 59746-245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Cadista Pharmacuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg Label (100mg Label)

Label for Lamotrigine Tablets, USP 100 mg oral tablets by Jubilant Cadista Pharmaceuticals Inc. The label indicates a package size of 100 tablets. It includes usage instructions such as storing at 20-25°C and keeping out of reach of children. The NDC number is 59746-246-01.*

FDA Label Image

150 mg Label (150mg Label)

Label for Lamotrigine Tablets, USP 150 mg by Jubilant Cadista Pharmaceuticals Inc. The label states each scored tablet contains 150 mg lamotrigine, includes storage and handling instructions, the NDC 59746-247-60, and a caution to verify the product dispensed. The package contains 60 tablets.*

FDA Label Image

200 mg Label (200mg Label)

Lamotrigine Tablets, USP 200 mg oral tablet label by Jubilant Cadista Pharmaceuticals Inc. The label states each scored tablet contains 200 mg lamotrigine and includes dosing instructions, storage conditions, and warnings to keep out of reach of children. The package contains 60 tablets.*

FDA Label Image

25 mg Label (25mg Label)

Label for Lamotrigine Tablets, USP 25 mg oral tablets by Jubilant Cadista Pharmaceuticals Inc. The label indicates a package of 100 scored tablets, with instructions to dispense with a medication guide and storage directions at controlled room temperature. The label highlights the 25 mg strength in a yellow box and includes caution to verify product dispensed.*

FDA Label Image

Figue 1 (Figure1)

A Kaplan-Meier curve chart showing failure probability (%) over weeks for Lamotrigine versus placebo. The chart includes two survival curves labeled Lamotrigine and Placebo, with time in weeks on the horizontal axis and failure probability percentage on the vertical axis. Censored data points are marked with '+' symbols on both curves.*

FDA Label Image

Figure 2 (Figure2)

A line graph comparing failure probability (%) over time (weeks) between Lamotrigine and Placebo groups. The x-axis represents weeks up to around 80, and the y-axis shows failure probability from 0 to 100%. Two curves labeled Lamotrigine and Placebo depict their respective failure probabilities, with censoring indicated.*

FDA Label Image

Chemical Structure (Lamotriginestructrue)

Chemical structure of lamotrigine, showing a chlorinated aromatic ring connected to a triazine ring with amino substituents, consistent with its molecular structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.